Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 159

Sort by

Sort Order Select

Journal Articles

Cytochrome-Derived EETs, VEGF-A, and NOX4: Piecing the Puzzle Together

Karin Jandeleit-Dahm, Jaroslawna Meister

Diabetes 2023;72(7):841–843

https://doi.org/10.2337/dbi23-0006

Published: 20 June 2023

View article titled, Cytochrome-Derived EETs, VEGF-A, and NOX4: Piecing the Puzzle Together

Meeting Abstracts

1491-P: ER Stress Drives the VEGF Expression in Monocytic Cells by Mechanisms Involving CHOP/ROS/HIF-1alpha/NRF2 and NF-kappaB/p38 MAPK Pathways

SARDAR A.K. SINDHU, NADEEM AKHTER, AJIT WILSON, HOSSEIN AREFANIAN, ASHRAF AL MADHOUN, REEBY S. THOMAS, SHIHAB P. KOCHUMON, FATEMA ALRASHED, FATEMAH BAHMAN, FAWAZ ALZAID, FAHD ALMULLA, RASHEED AHMAD

Diabetes 2023;72(Supplement_1):1491-P

https://doi.org/10.2337/db23-1491-P

Published: 20 June 2023

View article titled, 1491-P: ER Stress Drives the VEGF Expression in Monocytic Cells by Mechanisms Involving CHOP/ROS/HIF-1alpha/NRF2 and NF-kappaB/p38 MAPK Pathways

Meeting Abstracts

324-OR: VEGF Is a Contributing Factor for the Reduction of Retinal Function in Diabetic Retinopathy and Hypoxic Retinal Disorders

YUN LE, MEILI ZHU

Diabetes 2023;72(Supplement_1):324-OR

https://doi.org/10.2337/db23-324-OR

Published: 20 June 2023

View article titled, 324-OR: VEGF Is a Contributing Factor for the Reduction of Retinal Function in Diabetic Retinopathy and Hypoxic Retinal Disorders

Journal Articles

Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy

Stavroula Dionysopoulou, Per Wikstrom, Claudio Bucolo, Giovanni Luca Romano, Vincenzo Micale, Richard Svensson, Dimitris Spyridakos, Niki Mastrodimou, Spiros Georgakis, Panayotis Verginis, Erik Walum, Kyriaki Thermos

Diabetes 2023;72(5):638–652

https://doi.org/10.2337/db22-0515

Published: 23 February 2023

View article titled, Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy

Journal Articles

VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney Disease

Rachel Njeim, Kawthar Braych, Hilda E. Ghadieh, Nadim S. Azar, William S. Azar, Batoul Dia, Angelo Leone, Francesco Cappello, Hala Kfoury, Frederic Harb, Abdo R. Jurjus, Assaad A. Eid, Fuad N. Ziyadeh

Diabetes 2023;72(7):947–957

https://doi.org/10.2337/db22-0636

Published: 20 January 2023

View article titled, VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney Disease

Journal Articles

Identifying Hyperreflective Foci in Diabetic Retinopathy via VEGF-Induced Local Self-Renewal of CX3CR1⁺ Vitreous Resident Macrophages

Muneo Yamaguchi, Shintaro Nakao, Iori Wada, Tetsuya Matoba, Mitsuru Arima, Yoshihiro Kaizu, Mariko Shirane, Keijiro Ishikawa, Takahito Nakama, Yusuke Murakami, Masaharu Mizuochi, Wataru Shiraishi, Ryo Yamasaki, Toshio Hisatomi, Tatsuro Ishibashi, Masabumi Shibuya, Alan W. Stitt, Koh-Hei Sonoda

Diabetes 2022;71(12):2685–2701

https://doi.org/10.2337/db21-0247

Published: 07 October 2022

View article titled, Identifying Hyperreflective Foci in Diabetic Retinopathy via VEGF-Induced Local Self-Renewal of CX3CR1<sup>+</sup> Vitreous Resident Macrophages

Meeting Abstracts

484-P: Uncoupling of IL-1beta and VEGF-A Signaling Axis Contributes to Impaired Arteriogenesis in the Context of Aging and Diabetes Mellitus

CHRIS S. MANTSOUNGA, SHEILA SHARMA, CADENCE LEE, RACHEL CARLEY, GAURAV CHOUDHARY, ALAN R. MORRISON

Diabetes 2022;71(Supplement_1):484-P

https://doi.org/10.2337/db22-484-P

Published: 01 June 2022

View article titled, 484-P: Uncoupling of IL-1beta and VEGF-A Signaling Axis Contributes to Impaired Arteriogenesis in the Context of Aging and Diabetes Mellitus

Meeting Abstracts

24-OR: Podocyte Targeted Pyruvate Kinase M2 (PKM2) Activation Normalized Glomerular VEGF Expression, Mitochondrial Function, Fuel Metabolism, and Diabetic Nephropathy

JIALIN FU, TAKANORI SHINJO, QIAN LI, KYOUNGMIN PARK, MARC GREGORY YU, HISASHI YOKOMIZO, QIAN HUANG, I-HSIEN WU, GEORGE L. KING

Diabetes 2022;71(Supplement_1):24-OR

https://doi.org/10.2337/db22-24-OR

Published: 01 June 2022

View article titled, 24-OR: Podocyte Targeted Pyruvate Kinase M2 (PKM2) Activation Normalized Glomerular VEGF Expression, Mitochondrial Function, Fuel Metabolism, and Diabetic Nephropathy

Journal Articles

Endothelial Phospholipase Cγ2 Improves Outcomes of Diabetic Ischemic Limb Rescue Following VEGF Therapy

Diabetes 2022;71(5):1149–1165

https://doi.org/10.2337/db21-0830

Published: 22 February 2022

View article titled, Endothelial Phospholipase Cγ2 Improves Outcomes of Diabetic Ischemic Limb Rescue Following VEGF Therapy

Journal Articles

GPR40 Activation Abolishes Diabetes-Induced Painful Neuropathy by Suppressing VEGF-A Expression

Vanessa Königs, Sandra Pierre, Martin Schicht, Jessica Welss, Lisa Hahnefeld, Vittoria Rimola, Elke Lütjen-Drecoll, Gerd Geisslinger, Klaus Scholich

Diabetes 2022;71(4):774–787

https://doi.org/10.2337/db21-0711

Published: 21 January 2022

View article titled, GPR40 Activation Abolishes Diabetes-Induced Painful Neuropathy by Suppressing VEGF-A Expression

Meeting Abstracts

89-OR: Cardiovascular and Mortality Risk with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Inhibitors in Patients with Diabetic Retinopathy (DR)

MIIN ROH, HELEN TESFAYE, LLOYD P. AIELLO, SEOYOUNG C. KIM, ELISABETTA PATORNO

Diabetes 2021;70(Supplement_1):89-OR

https://doi.org/10.2337/db21-89-OR

Published: 01 June 2021

View article titled, 89-OR: Cardiovascular and Mortality Risk with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Inhibitors in Patients with Diabetic Retinopathy (DR)

Journal Articles

Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy

Priyamvada M. Pitale, Irina V. Saltykova, Yvonne Adu-Agyeiwaah, Sergio Li Calzi, Takashi Satoh, Shizuo Akira, Oleg Gorbatyuk, Michael E. Boulton, Machelle T. Pardue, W. Timothy Garvey, Mohammad Athar, Maria B. Grant, Marina S. Gorbatyuk

Diabetes 2021;70(8):1738–1753

https://doi.org/10.2337/db20-1268

Published: 11 May 2021

View article titled, Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy

Journal Articles

Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes

Andreia Goncalves, Alyssa Dreffs, Cheng-mao Lin, Sarah Sheskey, Natalie Hudson, Jason Keil, Matthew Campbell, David A. Antonetti

Diabetes 2021;70(7):1549–1560

https://doi.org/10.2337/db20-1220

Published: 21 April 2021

View article titled, Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes

Journal Articles

Endothelial Cells Derived From Patients With Diabetic Macular Edema Recapitulate Clinical Evaluations of Anti-VEGF Responsiveness Through the Neuronal Pentraxin 2 Pathway

Marta Vilà González, Magdalini Eleftheriadou, Sophia Kelaini, Hojjat Naderi-Meshkin, Shonagh Flanagan, Stephen Stewart, Gianni Virgili, David J. Grieve, Alan W. Stitt, Noemi Lois, Andriana Margariti

Diabetes 2020;69(10):2170–2185

https://doi.org/10.2337/db19-1068

Published: 13 August 2020

View article titled, Endothelial Cells Derived From Patients With Diabetic Macular Edema Recapitulate Clinical Evaluations of Anti-VEGF Responsiveness Through the Neuronal Pentraxin 2 Pathway

Meeting Abstracts

326-OR: Faricimab for Diabetic Macular Edema: A Novel Anti–Angiopoietin-2/Anti–Vascular Endothelial Growth Factor Bispecific Antibody in Clinical Trials

VEERAL SHETH, JAYASHREE SAHNI, IVAYLO STOILOV, JEFFREY R. WILLIS, ROBERT WEIKERT

Diabetes 2020;69(Supplement_1):326-OR

https://doi.org/10.2337/db20-326-OR

Published: 01 June 2020

View article titled, 326-OR: Faricimab for Diabetic Macular Edema: A Novel Anti–Angiopoietin-2/Anti–Vascular Endothelial Growth Factor Bispecific Antibody in Clinical Trials

Meeting Abstracts

591-P: Macrophage IL-1beta–Dependent VEGF-A Expression Is Required for Inflammatory Arteriogenesis and Wound Healing in Type 2 Diabetes

CHRIS S. MANTSOUNGA

Diabetes 2020;69(Supplement_1):591-P

https://doi.org/10.2337/db20-591-P

Published: 01 June 2020

View article titled, 591-P: Macrophage IL-1beta–Dependent VEGF-A Expression Is Required for Inflammatory Arteriogenesis and Wound Healing in Type 2 Diabetes

Meeting Abstracts

605-P: Endothelial-Specific Overexpression of Metallothionein Prevents Diabetes Mellitus–Induced Impairment in Ischemia Angiogenesis via Preservation of HIF-1a/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

KAI WANG, XIAOZHEN DAI, JING CHEN, FEIXIA SHEN, KUPPER A. WINTERGERST, PAUL N. EPSTEIN, LU CAI, YI TAN

Diabetes 2020;69(Supplement_1):605-P

https://doi.org/10.2337/db20-605-P

Published: 01 June 2020

View article titled, 605-P: Endothelial-Specific Overexpression of Metallothionein Prevents Diabetes Mellitus–Induced Impairment in Ischemia Angiogenesis via Preservation of HIF-1a/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

Journal Articles

Endothelial Overexpression of Metallothionein Prevents Diabetes-Induced Impairment in Ischemia Angiogenesis Through Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

Diabetes 2020;69(8):1779–1792

https://doi.org/10.2337/db19-0829

Published: 13 May 2020

View article titled, Endothelial Overexpression of Metallothionein Prevents Diabetes-Induced Impairment in Ischemia Angiogenesis Through Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

Journal Articles

Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF–Resistant Diabetic Macular Edema

Mitsuru Arima, Shintaro Nakao, Muneo Yamaguchi, Hao Feng, Yuya Fujii, Kensuke Shibata, Iori Wada, Yoshihiro Kaizu, Hamid Ahmadieh, Tatsuro Ishibashi, Alan W. Stitt, Koh-Hei Sonoda

Diabetes 2020;69(5):981–999

https://doi.org/10.2337/db19-1121

Published: 05 March 2020

View article titled, Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF–Resistant Diabetic Macular Edema

Includes: Supplementary data

Journal Articles

PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis

Wenyi Wu, Guohong Zhou, Haote Han, Xionggao Huang, Heng Jiang, Shizuo Mukai, Andrius Kazlauskas, Jing Cui, Joanne Aiko Matsubara, Bart Vanhaesebroeck, Xiaobo Xia, Jiantao Wang, Hetian Lei

Diabetes 2020;69(4):736–748

https://doi.org/10.2337/db19-0713

Published: 08 January 2020

View article titled, PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis

Includes: Supplementary data

NARROW

Cytochrome-Derived EETs, VEGF-A, and NOX4: Piecing the Puzzle Together

1491-P: ER Stress Drives the VEGF Expression in Monocytic Cells by Mechanisms Involving CHOP/ROS/HIF-1alpha/NRF2 and NF-kappaB/p38 MAPK Pathways

324-OR: VEGF Is a Contributing Factor for the Reduction of Retinal Function in Diabetic Retinopathy and Hypoxic Retinal Disorders

Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy

VEGF-A: A Novel Mechanistic Link Between CYP2C-Derived EETs and Nox4 in Diabetic Kidney Disease

Identifying Hyperreflective Foci in Diabetic Retinopathy via VEGF-Induced Local Self-Renewal of CX3CR1⁺ Vitreous Resident Macrophages

484-P: Uncoupling of IL-1beta and VEGF-A Signaling Axis Contributes to Impaired Arteriogenesis in the Context of Aging and Diabetes Mellitus

24-OR: Podocyte Targeted Pyruvate Kinase M2 (PKM2) Activation Normalized Glomerular VEGF Expression, Mitochondrial Function, Fuel Metabolism, and Diabetic Nephropathy

Endothelial Phospholipase Cγ2 Improves Outcomes of Diabetic Ischemic Limb Rescue Following VEGF Therapy

GPR40 Activation Abolishes Diabetes-Induced Painful Neuropathy by Suppressing VEGF-A Expression

89-OR: Cardiovascular and Mortality Risk with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Inhibitors in Patients with Diabetic Retinopathy (DR)

Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy

Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes

Endothelial Cells Derived From Patients With Diabetic Macular Edema Recapitulate Clinical Evaluations of Anti-VEGF Responsiveness Through the Neuronal Pentraxin 2 Pathway

326-OR: Faricimab for Diabetic Macular Edema: A Novel Anti–Angiopoietin-2/Anti–Vascular Endothelial Growth Factor Bispecific Antibody in Clinical Trials

591-P: Macrophage IL-1beta–Dependent VEGF-A Expression Is Required for Inflammatory Arteriogenesis and Wound Healing in Type 2 Diabetes

605-P: Endothelial-Specific Overexpression of Metallothionein Prevents Diabetes Mellitus–Induced Impairment in Ischemia Angiogenesis via Preservation of HIF-1a/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

Endothelial Overexpression of Metallothionein Prevents Diabetes-Induced Impairment in Ischemia Angiogenesis Through Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

Claudin-5 Redistribution Induced by Inflammation Leads to Anti-VEGF–Resistant Diabetic Macular Edema

PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only